Shed vs Telos Rx: Coaching and Name-Brand vs Compounded Options
Shed vs Telos Rx: choose Shed if you want integrated coaching and the option of FDA-approved name-brand GLP-1; choose Telos Rx if you prioritize lower starting pricing on compounded semaglutide. Early verdict: Shed stands out for coaching plus name-brand and compounded options, while Telos Rx emphasizes lower-priced compounded options starting as low as $99 per month if approved by a licensed provider.
Explore Shed’s name-brand and compounded options
Shed vs Telos Rx: how they differ at a glance
Both platforms require clinician review and offer GLP-1 medications, but their models differ on medication types, pricing cues, coaching, and speed of initial assessment.
| Criteria | Shed | Telos Rx |
|---|---|---|
| Medication types | Offers both FDA-approved name-brand GLP-1 and compounded options | Compounded semaglutide and tirzepatide only (per captured evidence) |
| Starting price | Compounded semaglutide starting at $199/month; tirzepatide starting at $299/month; 10% off first month | Semaglutide as low as $99/month; tirzepatide as low as $139/month if approved |
| Coaching | Continuous integrated coaching included in treatment | Care team model described, but no integrated coaching claim captured |
| Approval process | 2-minute online eligibility assessment, then clinician review | Treatment prescribed only after review by a US-licensed provider |
| Regulatory note | Compounded medications are not FDA-approved (explicit) | Compounded medications are not FDA-approved (explicit) |
Medication options: name-brand availability vs compounded focus
Shed documents offering both FDA-approved name-brand GLP-1 and compounded alternatives on one platform, letting patients choose by budget and preference. Telos Rx, as captured, offers compounded semaglutide and tirzepatide prescribed after clinician review. Both sources preserve the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
See Telos Rx compounded pricing and eligibility
Pricing and offers: starting rates and first-month promotion
Shed lists compounded semaglutide starting at $199/month and compounded tirzepatide starting at $299/month and advertises 10% off your first month for new patients. Telos Rx shows semaglutide as low as $99/month and tirzepatide as low as $139/month, with pricing and plan details subject to clinician approval and the live offer. Both emphasize that final price depends on the plan and clinician decision.
Check Shed’s starting plans and 10% first-month offer
Care model and assessment speed
Shed highlights continuous coaching integrated into treatment and a 2-minute online approval assessment followed by clinician review. Telos Rx describes clinician-reviewed prescribing for compounded GLP-1 medications but captured evidence does not document an equivalent fast assessment or integrated coaching model. If coaching during titration and lifestyle support matters, Shed documents that as a core feature.
Safety, regulation, and clinician role
Both providers’ captured evidence states that compounded medications are prescription-only and not FDA-approved. Each platform requires a licensed clinician to determine whether treatment is appropriate before issuing a prescription. Neither source provides outcome guarantees; Shed notes results may vary and refers to Terms and Conditions for its weight-loss guarantee details. Telos Rx captured evidence also notes individual results vary and are not guaranteed.
Review Telos Rx clinician review terms
Which matters most: five quick takeaways
- Medication choice: Shed includes name-brand plus compounded; Telos Rx captured evidence focuses on compounded options.
- Price cue: Telos Rx lists lower as-low-as rates for compounded semaglutide ($99) and tirzepatide ($139); Shed lists higher starting compounded prices but offers 10% off first month.
- Coaching: Shed documents continuous coaching integrated into treatment; Telos Rx evidence does not capture the same coaching claim.
- Assessment: Shed advertises a 2-minute eligibility assessment then clinician review; Telos Rx requires clinician approval without a captured 2-minute claim.
- Regulatory: Both note compounded medications are not FDA-approved and are prescribed after clinician review.
Conclusion: final comparison and who to choose
In the Shed vs Telos Rx comparison, Shed is the better fit for people who want access to FDA-approved name-brand GLP-1 options plus compounded alternatives, combined with integrated coaching and a fast 2-minute assessment. Telos Rx is the clearer choice for those focused on lower advertised starting prices for compounded semaglutide or tirzepatide, subject to clinician approval and the live offer.
Choose Shed if you want name-brand options, continuous coaching, and a quick 2-minute eligibility assessment. Choose Telos Rx if you prioritize lower starting compounded prices and clinician-reviewed prescribing.